Hypophosphataemia in severe acute malnutrition: a prospective observational study. Issue 3 (17th December 2018)

• Record Type: Journal Article
• Authors: Chanchal, Rana; Gupta, Sarika; Kanta, Chandra; Singh, Kalpana; Koonwar, Sciddhartha
• Is Part Of: British journal of nutrition. Volume 121:Issue 3(2019)
• Page Start: 306
• Page End: 311
• Publication Date: 2018-12-17
• Subjects: Hypophosphataemia, -- Severe acute malnutrition, -- Hypocalcaemia, -- Refeeding; Nutrition -- Periodicals; 572.4
• DOI: 10.1017/S0007114518003197
• Languages: English
• ISSNs: 0007-1145

Abstract

Abstract: Severe acute malnutrition (SAM) is a major cause of child mortality and morbidity. Children treated for SAM are at risk of refeeding hypophosphataemia (HP). The study was done to find out the incidence and various predictors of moderate/severe HP in SAM among North Indian children. This prospective observational study was conducted from August 2014 to July 2015 in the inpatients' department of Department of Paediatrics at King George's Medical University, Lucknow, Uttar Pradesh, North India, a tertiary care teaching hospital. Before inclusion, ethical approval and written informed consent was obtained. Included in the study were sixty-five children aged 6–59 months of age, who were admitted to the hospital with SAM as per the WHO guidelines. SAM was defined as a mid-upper arm circumference <115 mm and/or weight-for-height/length <–3 z -scores of the WHO growth standards and/or have bilateral oedema. Serum P levels were measured on admission and for five consecutive days after starting feed. HP was defined as mild, moderate and severe with a cut-off of 1·19–0·65, 0·65–0·32 and <0·32 mmol/l, respectively. About 60 % children had HP, with 20 % having moderate/severe HP at admission. The proportion of HP increased to 83·1 %, with 38·5 % having moderate/severe HP on day 3 after feeding. It was concluded that HP is a common biochemical abnormality in SAM. Considering its impact on the health of the child, serum P levels should be monitored in patients with SAM who are treated with enteral feeding.